Structure Therapeutics is a pioneering brand dedicated to designing advanced and orally available medicines that have the power to transform patients' lives worldwide. By harnessing the potential of cutting-edge computing and structure-based technologies, Structure Therapeutics strives to revolutionize the field of medicine, making it more effective and accessible for all. Their mission is clear: to create better medicines for everyone.

Structure Therapeutics specializes in the development of small molecule drugs that can be taken orally, ensuring convenience and ease for patients. Their platform utilizes state-of-the-art visualization techniques, computational chemistry, and data integration to develop innovative medicines with biologic-like activity and specificity. This approach overcomes the limitations of traditional biologic and peptide drugs.

With a strong focus on chronic diseases with unmet global needs, Structure Therapeutics is driving multiple pipeline programs in areas such as type 2 diabetes mellitus, obesity, and pulmonary diseases. With top talent and resources available in the US and China, Structure Therapeutics is well-positioned to deliver world-class medicines that make a difference in patients' lives